APNIMED THERAPEUTICS Trademark

Trademark Overview

On Saturday, August 8, 2020, a trademark application was filed for APNIMED THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the APNIMED THERAPEUTICS trademark a serial number of 90101180. The federal status of this trademark filing is FIFTH EXTENSION - GRANTED as of Thursday, August 31, 2023. This trademark is owned by Apnimed, Inc.. The APNIMED THERAPEUTICS trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Research and development of pharmaceuticals and biopharmaceuticals
apnimed therapeutics

General Information

Serial Number90101180
Word MarkAPNIMED THERAPEUTICS
Filing DateSaturday, August 8, 2020
Status734 - FIFTH EXTENSION - GRANTED
Status DateThursday, August 31, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 12, 2021

Trademark Statements

Disclaimer with Predetermined Text"THERAPEUTICS"
Goods and ServicesResearch and development of pharmaceuticals and biopharmaceuticals

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, September 9, 2020
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameApnimed, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02138
Party NameApnimed, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02138

Trademark Events

Event DateEvent Description
Friday, September 1, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, August 31, 2023SOU EXTENSION 5 GRANTED
Thursday, August 24, 2023SOU EXTENSION 5 FILED
Wednesday, August 30, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, August 24, 2023SOU TEAS EXTENSION RECEIVED
Thursday, March 9, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, March 7, 2023SOU EXTENSION 4 GRANTED
Tuesday, March 7, 2023SOU EXTENSION 4 FILED
Tuesday, March 7, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, August 16, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, August 12, 2022SOU EXTENSION 3 GRANTED
Friday, August 12, 2022SOU EXTENSION 3 FILED
Friday, August 12, 2022SOU TEAS EXTENSION RECEIVED
Saturday, February 12, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, February 10, 2022SOU EXTENSION 2 GRANTED
Thursday, February 10, 2022SOU EXTENSION 2 FILED
Thursday, February 10, 2022SOU TEAS EXTENSION RECEIVED
Tuesday, July 6, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, July 2, 2021SOU EXTENSION 1 GRANTED
Friday, July 2, 2021SOU EXTENSION 1 FILED
Friday, July 2, 2021SOU TEAS EXTENSION RECEIVED
Tuesday, March 9, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, January 12, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 12, 2021PUBLISHED FOR OPPOSITION
Wednesday, December 23, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, December 9, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, December 9, 2020EXAMINER'S AMENDMENT ENTERED
Wednesday, December 9, 2020NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, December 9, 2020EXAMINERS AMENDMENT E-MAILED
Wednesday, December 9, 2020EXAMINERS AMENDMENT -WRITTEN
Wednesday, December 2, 2020ASSIGNED TO EXAMINER
Wednesday, September 9, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, August 24, 2020TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED
Monday, August 24, 2020TEAS VOLUNTARY AMENDMENT RECEIVED
Wednesday, August 12, 2020NEW APPLICATION ENTERED

Related Keywords

therapeutics apnimed biopharmaceuticals pharmaceuticals development research